Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Clobetasol propionate

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44363   clinical trials with a EudraCT protocol, of which   7387   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    25 result(s) found for: Clobetasol propionate. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2005-004161-41 Sponsor Protocol Number: CL-068-II-01 Start Date*: 2005-12-15
    Sponsor Name:Idea AG
    Full Title: Efficacy and Safety of IDEA-068 in Plaque Psoriasis
    Medical condition: chronic stable plaque type psoriasis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006487-32 Sponsor Protocol Number: RD.03.SPR. 40041 Start Date*: 2007-02-27
    Sponsor Name:GALDERMA R&D SNC
    Full Title: CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 µg/g WITH THREE CONCENTRATIONS (100, 250, 500µg/g) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ...
    Medical condition: Treatment of psoriasis vulgaris
    Disease: Version SOC Term Classification Code Term Level
    9.1 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2006-006569-18 Sponsor Protocol Number: V00074 VE 202 04A Start Date*: 2007-03-16
    Sponsor Name:PIERRE FABRE DERMATOLOGIE represented by INSTITUT DE RECHERCHE PIERRE FABRE
    Full Title: EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS
    Medical condition: NAIL PSORIASIS
    Disease: Version SOC Term Classification Code Term Level
    9.1 10028703 Nail psoriasis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2006-005602-31 Sponsor Protocol Number: mec 06/239 Start Date*: 2006-10-24
    Sponsor Name:Academic Medical Center
    Full Title: Excimer laser versus clobetason propionaat in prurigo form of atopic dermatitis
    Medical condition: the excimer laser appears to be a promising treatment for localized atopic dermatitis. Therefore we designed a randomized trial to investigate the efficacy of this excimer laser versus topical clob...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2006-003073-27 Sponsor Protocol Number: RD.03.SPR29064 Start Date*: 2007-02-06
    Sponsor Name:Galderma R&D
    Full Title: Subject preference comparison between Clobetasol propionate shampoo, 0.05% and three other topical corticosteroids in the treatment of moderate to severe Scalp psoriasis
    Medical condition: Moderate to Severe Scalp Psoriasis with a Global Severity Score of 3 at least on a scale from 0 to 5.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10037157 Psoriasis of scalp LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed) IT (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2021-000865-33 Sponsor Protocol Number: HUA_AFF_PRP_21 Start Date*: 2021-10-05
    Sponsor Name:INSTITUTO DE INVESTIGACIÓN SANITARIA BIOARABA
    Full Title: Randomized, parallel controlled study with routine clinical practice to evaluate the efficacy and tolerability of PRFC ENDORET® in the treatment of frontal fibrosing alopecia
    Medical condition: • Patients diagnosed with fibrosing frontal alopecia (FFA) with an age greater than or equal to 18 years. • Patient not responding to previous treatments for at least 6 months. • Use of effective...
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2022-000624-37 Sponsor Protocol Number: CLOBOF3-17IA03 Start Date*: 2022-10-05
    Sponsor Name:Laboratorios Salvat, S.A.
    Full Title: A Phase 3, multicenter, randomized, evaluator-blinded clinical trial to assess the safety and efficacy of Clobetasol propionate ophthalmic nanoemulsion, 0.05% compared to Prednisolone acetate, 1% i...
    Medical condition: Inflammation and pain associated with ocular surgery.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10015919 - Eye disorders 10015943 Eye inflammation PT
    20.0 10015919 - Eye disorders 10015958 Eye pain PT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2009-010357-12 Sponsor Protocol Number: 43/2009 Start Date*: 2009-03-16
    Sponsor Name:POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI
    Full Title: Hypothalamus-Pituitary-Adrenal Axis function in the topical management with clobetasol propionate of oral lichen planus (OLP
    Medical condition: oral lichen planus
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030983 Oral lichen planus LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2014-000547-32 Sponsor Protocol Number: 13123 Start Date*: 2014-04-02
    Sponsor Name:University of Nottingham
    Full Title: A Randomised Controlled Trial of Adjunctive Systemic Therapy for Vulval Erosive Lichen Planus
    Medical condition: Vulval erosive lichen planus
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004872 10047727 Vulva disorder LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2016-003952-63 Sponsor Protocol Number: LIQUENIA Start Date*: 2017-07-07
    Sponsor Name:Instituto de Investigación Sanitaria La Fe
    Full Title: Pilot study of vulval lichen sclerosus treatment by adipose tissue associated with autologous platelet-rich plasma
    Medical condition: Vulval lichen sclerosus
    Disease: Version SOC Term Classification Code Term Level
    19.1 100000004858 10047761 Vulval lichen sclerosus et atrophicus LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-005217-22 Sponsor Protocol Number: RD.03.SPR.29079 Start Date*: 2009-03-04
    Sponsor Name:Galderma Research & Development
    Full Title: Efficacy and Safety of Clobetasol propionate shampoo 0.05% used in association with an antifungal shampoo in the treatment of moderate to severe Scalp Seborrheic Dermatitis
    Medical condition: moderate to severe Scalp Seborrheic Dermatitis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 Seborrheic dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2011-005984-25 Sponsor Protocol Number: 28-11-2011version1 Start Date*: 2012-02-15
    Sponsor Name:Bispebjerg Hospital
    Full Title: Inflammation after photodynamic therapy of actinic keratoses
    Medical condition: Actinic keratoses
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2008-004331-38 Sponsor Protocol Number: olux 01/08 Start Date*: 2008-08-28
    Sponsor Name:MIPHARM
    Full Title: Randomized study on the effectiveness, safety and acceptability 'of clobetasol propionate foam-cooled (OLUX) in comparison with cream aceponato methylprednisolone in the treatment of allergic conta...
    Medical condition: Patients suffering from mild to moderate DAC with interest of body surface area not exceeding 20%
    Disease: Version SOC Term Classification Code Term Level
    9.1 10056265 Allergic contact dermatitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2017-002193-40 Sponsor Protocol Number: DT-001-R-004 Start Date*: 2018-04-04
    Sponsor Name:Afyx Therapeutics A/S
    Full Title: A Randomized, Double-blind, Placebo-controlled, Parallel Group Clinical Study to Assess the Safety and Efficacy of Three Doses of Clobetasol Propionate when Administered Intra-orally Twice Daily in...
    Medical condition: Oral Lichen Planus (OLP). OLP is a common, chronic mucosal disease associated with a cell-mediated immunological dysfunction and characterized by exacerbations of inflammation, which can lead to ul...
    Disease: Version SOC Term Classification Code Term Level
    20.1 10017947 - Gastrointestinal disorders 10030983 Oral lichen planus PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IE (Completed) DK (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-000582-11 Sponsor Protocol Number: 251106BS Start Date*: 2006-07-14
    Sponsor Name:ALTANA Inc
    Full Title: Determination of anti-inflammatory efficacy of topical formulations in a UV erythema test
    Medical condition: Healthy subjects will be included in the study. The new generic formulation is intended to be used in the topical treatment of inflammatory processes.
    Disease:
    Population Age: Adults Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-001678-34 Sponsor Protocol Number: wa+tr_1 Start Date*: 2008-08-20
    Sponsor Name:Department of dermatology, Odense University Hospital
    Full Title: Examination of the efficacy of glycerol, two topical steroids and a topical immune modulator in experimentally induced skin irritation
    Medical condition: Irritative contact dermatitis.
    Disease: Version SOC Term Classification Code Term Level
    9.1 10010792 Contact dermatitis and other eczema due to detergents LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2020-002201-25 Sponsor Protocol Number: CHDR2007 Start Date*: 2020-12-14
    Sponsor Name:Centre for Human Drug Research
    Full Title: A two-part (observational and intervention) study to explore disease characteristics of vulvar (pre)malignancies compared to healthy volunteers
    Medical condition: lichen sclerosus, vulvar (pre)malignancies
    Disease:
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2013-002583-80 Sponsor Protocol Number: 38814 Start Date*: 2013-09-06
    Sponsor Name:Department of Dermatology, Bispebjerg University Hospital
    Full Title: Treatment of Actinic Keratoses with Ingenol Mebutate and topical glucocorticosteroid - a safety study
    Medical condition: Actinic Keratoses
    Disease: Version SOC Term Classification Code Term Level
    14.1 10040785 - Skin and subcutaneous tissue disorders 10000614 Actinic keratosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-001371-20 Sponsor Protocol Number: 18-PP-03 Start Date*: 2018-06-11
    Sponsor Name:CHU de Nice
    Full Title: Study of the role of local treatments on the modulation of the microbiome in psoriatic skin
    Medical condition: Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004858 10050576 Psoriasis vulgaris LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-006704-10 Sponsor Protocol Number: MICUMA Start Date*: 2007-03-16
    Sponsor Name:JADO Technologies GmbH
    Full Title: Efficacy and Safety of Miltefosine in Cutaneous Mastocytosis
    Medical condition: chronic stable symptomatic maculopapulous cutaneous mastocytosis or systemic mastocytosis with involvement of the skin and with positive Darier´s sign
    Disease: Version SOC Term Classification Code Term Level
    9.1 10012812 Diffuse cutaneous mastocytosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Mon Nov 03 22:02:52 CET 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA